Free Trial

Aileron Therapeutics (ALRN) SEC Filings & 10K Form

Aileron Therapeutics logo
$2.76 -0.06 (-2.13%)
(As of 11/20/2024 ET)

Recent Aileron Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:03 PM
Aileron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
4:17 PM
Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
Form SCHEDULE 13G/A
08/22/2024
3:05 PM
Aileron Therapeutics (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM
Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM
Aileron Therapeutics (Issuer)
Fairey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:07 PM
Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM
Aileron Therapeutics (Issuer)
Aivado Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:12 PM
Aileron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
4:23 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:29 PM
Aileron Therapeutics (Filer)
Form 424B5
07/26/2024
3:33 PM
Aileron Therapeutics (Filer)
Form 424B5
07/26/2024
3:36 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
7:41 AM
Aileron Therapeutics (Filer)
Form ARS
07/09/2024
7:30 AM
Aileron Therapeutics (Filer)
Form DEF 14A
07/09/2024
7:36 AM
Aileron Therapeutics (Filer)
Form DEFA14A
06/17/2024
6:03 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
5:18 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:59 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:58 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:19 PM
Aileron Therapeutics (Issuer)
Cunningham Timothy M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2024
4:16 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:54 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4/A
05/01/2024
6:15 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
4:24 PM
Aileron Therapeutics (Filer)
Form 424B5
05/01/2024
4:25 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
4:16 PM
Aileron Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:40 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:54 AM
Aileron Therapeutics (Subject)
Form FWP
04/30/2024
2:32 PM
Aileron Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2024
7:33 AM
Aileron Therapeutics (Filer)
Form 10-K/A
04/16/2024
4:16 PM
Aileron Therapeutics (Subject)
Satter Muneer A (Filed by)
Form SC 13D/A
04/15/2024
4:21 PM
Aileron Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
4:22 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:15 PM
Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4/A
04/10/2024
3:15 PM
Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4/A
04/02/2024
5:10 PM
Aileron Therapeutics (Issuer)
Garner Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
3:15 PM
Aileron Therapeutics (Filer)
Form NT 10-K
03/29/2024
7:03 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
6:00 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:06 PM
Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:14 PM
Aileron Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Filed by)
Form SC 13G
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

03/01/2024
3:05 PM
Aileron Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:05 PM
Aileron Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:01 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
9:28 AM
Aileron Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/13/2024
6:01 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
11:15 PM
Aileron Therapeutics (Filer)
Form EFFECT
02/05/2024
12:20 PM
Aileron Therapeutics (Subject)
Kapnick Scott (Filed by)
Form SC 13G/A
01/29/2024
7:46 AM
Aileron Therapeutics (Filer)
Form DEF 14A
01/29/2024
7:48 AM
Aileron Therapeutics (Filer)
Form ARS
01/29/2024
7:14 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
6:00 AM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:44 PM
Aileron Therapeutics (Filer)
Form PRE 14A
01/11/2024
3:18 PM
Aileron Therapeutics (Filer)
Form 8-K/A
01/10/2024
3:08 PM
Aileron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
4:56 PM
Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:43 PM
Aileron Therapeutics (Issuer)
WINDSOR JAMES BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALRN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners